ETF · holdings as filed 2026-04-30

What's inside FBTAX?

Fidelity Advisor Biotechnology Fund
Holdings
88
positions in the fund
Top 10
48%
of fund assets
Expense ratio
0.96%
net, per year
Fund size
$2B
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
A
ABBVABBVIE INC
14.46%
2
A
ALNYALNYLAM PHARMACEUTICALS INC
5.38%
3
G
GILDGILEAD SCIENCES INC
5.29%
4
I
INSMINSMED INC
3.42%
5
C
COGTCOGENT BIOSCIENCES INC
3.36%
6
D
DNTHDIANTHUS THERAPEUTICS INC
3.28%
7
S
SYRESPYRE THERAPEUTICS INC
3.25%
8
A
ASNDASCENDIS PHARMA A/S
3.16%
9
A
ARGXARGENX SE - ADR
3.09%
10
B
BIIBBIOGEN INC
2.85%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
A
ABBVABBVIE INC
14.46%
2
A
ALNYALNYLAM PHARMACEUTICALS INC
5.38%
3
G
GILDGILEAD SCIENCES INC
5.29%
4
I
INSMINSMED INC
3.42%
5
C
COGTCOGENT BIOSCIENCES INC
3.36%
6
D
DNTHDIANTHUS THERAPEUTICS INC
3.28%
7
S
SYRESPYRE THERAPEUTICS INC
3.25%
8
B
BIIBBIOGEN INC
2.85%
9
O
ORKAORUKA THERAPEUTICS INC
2.58%
10
A
AMGNAMGEN INC
2.40%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold FBTAX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.